相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
Huiyan Luo et al.
TRENDS IN MOLECULAR MEDICINE (2021)
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Wei Cao et al.
CHINESE MEDICAL JOURNAL (2021)
Silver telluride nanoparticles as biocompatible and enhanced contrast agents for X-ray imaging: an in vivo breast cancer screening study
Lenitza M. Nieves et al.
NANOSCALE (2021)
The potential of ctDNA analysis in breast cancer
Eleni Tzanikou et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)
The Predictive Value of Early Changes in 18F-Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
Min He et al.
ONCOLOGIST (2020)
Cancer burden of major cancers in China: A need for sustainable actions
Maomao Cao et al.
CANCER COMMUNICATIONS (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing
Haikun Zhang et al.
BMC MEDICINE (2020)
A review on methods for diagnosis of breast cancer cells and tissues
Ziyu He et al.
CELL PROLIFERATION (2020)
Abbreviated Magnetic Resonance Imaging (MRI) for Breast Cancer Screening: Rationale, Concept, and Transfer to Clinical Practice
Christiane K. Kuhl
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
Ning Jia et al.
FRONTIERS IN GENETICS (2019)
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
Giuseppe Buono et al.
CANCER TREATMENT REVIEWS (2019)
Epigenetics of hepatocellular carcinoma
Tan Boon Toh et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)
Wenhua Liang et al.
THERANOSTICS (2019)
The future of blood-based biomarkers for the early detection of breast cancer
Sau Yeen Loke et al.
EUROPEAN JOURNAL OF CANCER (2018)
Breast cancer diagnosis: Imaging techniques and biochemical markers
Seyed Hamed Jafari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker
Mersedeh Rohanizadegan
CANCER GENETICS (2018)
DNA Methylation Patterns in Normal Tissue Correlate more Strongly with Breast Cancer Status than Copy-Number Variants
Yang Gao et al.
EBIOMEDICINE (2018)
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala et al.
BMC MEDICINE (2018)
Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
Jose Marrugo-Ramirez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker
Abu Ali Ibn Sina et al.
NATURE COMMUNICATIONS (2018)
Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
Mao Shang et al.
JOURNAL OF CANCER (2018)
Integrating radiologist feedback with computer aided diagnostic systems for breast cancer risk prediction in ultrasonic images: An experimental investigation in machine learning paradigm
Bikesh Kumar Singh et al.
EXPERT SYSTEMS WITH APPLICATIONS (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
Shicheng Guo et al.
NATURE GENETICS (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano et al.
ANNALS OF ONCOLOGY (2017)
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
Susan M. Mitchell et al.
GENES (2016)
Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer
Christophe Legendre et al.
CLINICAL EPIGENETICS (2015)
Overview of digital breast tomosynthesis: Clinical cases, benefits and disadvantages
T. Nguyen et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2015)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Felix Krueger et al.
BIOINFORMATICS (2011)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
分享论文
